Valiant Laboratories Limited is an India-based pharmaceutical ingredient manufacturing company. The Company is focused on manufacturing a Paracetamol active pharmaceutical ingredient (API)/bulk drug. It has several applications in the treatment of conditions such as headache, muscle ache, arthritis, backache, toothache, cold and fever. It is also used in the management of severe pain such as post-surgical and cancer pain. It operates a single-location manufacturing facility on the Tarapur industrial estate.

Employees

Sector

Specialty Chemicals

More about the company

Quotes

Date	Price	Change	Volume
03/09/26	₹100.93	+4.99%	44,968
02/09/26	₹96.13	+4.99%	296,583
01/09/26	₹91.56	-4.96%	97,464
31/08/26	₹96.34	-3.32%	248,647
28/08/26	₹99.65	-5.00%	94,454

End-of-day quote NSE India S.E.

More quotes

End-of-day quote NSE India S.E. 02/09/2026			5-day change	1st Jan Change
96.13 ^INR	+4.99%		-10.88%	+37.33%

08-10	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-10	Valiant Laboratories Limited Approves the Opening of New Corporate Office	CI

Market Cap	2.8B 29.66M 25.52M 23.95M 21.91M 40.89M 41.22M 283M 110M 1.43B 111M 109M 4.61B	P/E 2024	1,725x	P/E 2025	-150x
Enterprise Value	3.26B 34.45M 29.64M 27.81M 25.45M 47.5M 47.87M 329M 128M 1.66B 129M 127M 5.36B	EV / Sales 2024	3.09x	EV / Sales 2025	2.83x
Free-Float	23.22%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
NSE India S.E.	VALIANTLAB	End-of-day quote
Bombay S.E.	VALIANTLAB	Delayed

08-10	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-10	Valiant Laboratories Limited Approves the Opening of New Corporate Office	CI
05-20	Valiant Organics Limited agreed to acquire 34.26% stake in Valiant Laboratories Limited from Dhanvallabh Ventures LLP.	CI
05-14	Valiant Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-23	Valiant Laboratories Limited Announces Resignation of Bhanudas D. Patil as Q.C Manager, Senior Management Personnel, Effective April 22, 2026	CI
02-11	Valiant Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
01-15	Valiant Laboratories Ltd receives notice for total tax demand of approx. 125.3 million rupees	RE
11-11	Valiant Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
11-07	Valiant Laboratories Arm Begins Commercial Operations at New Unit in Gujarat, India; Shares Up 4%	MT
25/09/25	Valiant Laboratories Limited Approves Change in Designation of Paresh Shah from Executive Director to Whole-Time Director, Effective September 25, 2025	CI
08/08/25	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
16/07/25	Valiant Laboratories Gets Board Nod for INR815 Million Rights Issue; Shares Up 4%	MT
15/07/25	Valiant Laboratories says rights issue price set at 75 rupees per share, entitlement ratio 1:4	RE

Valiant Laboratories Limited Stock

Stocks

VALIANTLAB

INE0JWS01017

Specialty Chemicals

Valuation : Valiant Laboratories Limited

Chart: Valiant Laboratories Limited

Latest news : Valiant Laboratories Limited

Quotes and Performance

Price Extremes

Managers and Directors : Valiant Laboratories Limited

Other Specialty Chemicals

Financials

Company Profile

Quotes

1 day	+4.99%
1 week	-10.88%
Current month	-0.22%
1 month	+58.26%
3 months	+25.23%
6 months	+70.47%
Current year	+37.33%

1 week	91.53	108.75
1 month	60	110.7
Current year	49.51	110.7
1 year	49.51	110.7
3 years	49.51	214.95
5 years	49.51	214.95
10 years	49.51	214.95

Manager	Title	Age	Since
Santosh Vora CEO	Chief Executive Officer	32	21/08/2021
Paresh Shah DFI	Director of Finance/CFO	66	16/08/2021
Akshay Dnyaneshwar Gangurde CMP	Compliance Officer	-	09/07/2025

Director	Title	Age	Since
Santosh Vora BRD	Director/Board Member	32	21/08/2021
Sonal Amit Vira BRD	Director/Board Member	43	16/02/2022
Paresh Shah BRD	Director/Board Member	66	16/08/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VALIANT LABORATORIES LIMITED	+4.99%	-10.88%	+10.86%	-	55.27M
ECOLAB INC.	-0.33%	-2.43%	+2.10%	+53.20%	78.46B
SIKA AG	+0.93%	-1.97%	+4.64%	-23.36%	37.03B
GIVAUDAN SA	+2.40%	-2.70%	-3.41%	+12.05%	36.41B
FUJIFILM HOLDINGS CORPORATION	-0.66%	+0.73%	-6.89%	+15.60%	25.22B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-1.68%	-0.81%	+82.65%	+26.35%	23.18B
EMS-CHEMIE HOLDING AG	-0.25%	+2.46%	+31.34%	+18.71%	22.79B
DUPONT DE NEMOURS, INC.	-1.35%	-5.53%	-42.16%	-42.02%	17.95B
ALBEMARLE CORPORATION	-4.06%	-2.66%	+64.97%	-34.18%	16.26B
NITTO DENKO CORPORATION	+0.09%	+2.33%	+2.78%	+72.09%	14.52B
Average	+0.02%	-1.11%	+14.69%	+10.94%	27.19B
Weighted average by Cap.	-0.19%	-1.43%	+11.07%	+18.09%

	2024	2025
Net sales	1.82B 19.26M 16.57M 15.55M 14.23M 26.55M 26.76M 184M 71.64M 930M 72.32M 70.74M 3B	1.33B 14.11M 12.14M 11.39M 10.42M 19.45M 19.61M 135M 52.48M 682M 52.99M 51.83M 2.2B
Net income	3.2M 33.81K 29.09K 27.3K 24.98K 46.62K 46.98K 323K 126K 1.63M 127K 124K 5.26M	-22.01M -233K -200K -188K -172K -321K -324K -2.22M -866K -11.25M -874K -855K -36.23M
Net Debt	-671M -7.1M -6.11M -5.73M -5.24M -9.79M -9.87M -67.81M -26.41M -343M -26.66M -26.08M -1.1B	453M 4.79M 4.12M 3.87M 3.54M 6.61M 6.66M 45.76M 17.82M 231M 17.99M 17.6M 745M